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ABSTRACT
Objective To determine the rates of death and infection
from HIV in India.
Design Nationally representative survey of deaths.
Setting 1.1 million homes in India.
Population123000deathsatallagesfrom2001to2003.
Main outcome measures HIV mortality and infection.
ResultsHIV accounted for 8.1% (99% confidence interval
5.0% to 11.2%) of all deaths among adults aged
25-34 years. In this age group, about 40% of deaths from
HIV were due to AIDS, 26% were due to tuberculosis, and
the rest were attributable to other causes. Nationally, HIV
infection accounted for about 100000 (59000 to
140000) deaths or 3.2% (1.9% to 4.6%) of all deaths
among people aged 15-59 years. Deaths from HIV were
concentrated in the states and districts with higher HIV
prevalenceand in men.The mortality results implyan HIV
prevalenceatage15-49yearsof0.26%(0.13%to0.39%)
in 2004, comparable to results from a 2005/6 household
survey that tested for HIV (0.28%). Collectively, these
data suggest that India had about 1.4-1.6 million HIV
infected adults aged 15-49 years in 2004-6, about 40%
lowerthantheofficialestimateof2.3 millionfor2006.All
cause mortality increased in men aged 25-34 years
between 1997 and 2002 in the states with higher HIV
prevalence but declined after that. HIV prevalence in
young pregnant women, a proxy measure of incidence in
the general population, fell between 2000 and 2007.
Thus, HIV mortality and prevalence may have fallen
further since our study.
ConclusionHIVattributabledeathandinfectioninIndiais
substantial, although it is lower than previously
estimated.
INTRODUCTION
In India, and most other countries, heterosexual trans-
mission accounts for most HIV infections.
1 Transmis-
sion from female sex workers to male clients, and then
to these clients’ regular partners, is the most common
chain of infection.
2-5
Because clinical testing is uncommon, India, like
mostlowincomecountries,uses“sentinelsurveillance”
of anonymous, unlinked testing of pregnant women to
monitortrendsinHIVamongthegeneralpopulation.
67
WehavepreviouslyreportedthattheincidenceofHIV,
measuredindirectlythroughprevalenceinyoungpreg-
nant women aged 15-24 years, fell by nearly 50% in
selectedstatesbetween2000and2007.
89However,sen-
tinel surveillance, although useful to estimate trends,
cannot estimate reliably the absolute prevalence of
HIV in India or HIV attributable mortality.
10
The government of India officially revised its esti-
mate of the prevalence of HIV in adults aged
15-59 years from 5.1 million to 2.5 million (range 2.0-
3.1 million) in 2006.
1112 The revision was partly
because a nationally representative HIV prevalence
survey in 2005/6 found the prevalence at ages
15-49yearstobelessthanhalfofthatestimatedearlier
from sentinel surveillance.
1213 The earlier sentinel sur-
veillance data were used by the World Health Organi-
zation to estimate that between 270000 and 630000
deaths from HIV occurred in 2003.
14 WHO subse-
quently reduced this to 127000 deaths in 2004 on the
basis of the results of the 2005/6 survey.
15
However, the 2005/6 survey of HIV faced methodo-
logicalproblems,
2anditsestimateofHIVprevalencehas
not been confirmed. Thus, direct, independent estimates
ofHIVattributablemortalitywouldbeimportanttocon-
firm the relations between new and prevalent infections
andmortalityandalsotoplantreatmentservices.
16Inthis
paper, we provide estimates of HIV attributable mortal-
ity from the first ever nationally representative survey of
deaths,
17 carried out in 1.1 million homes. We also esti-
m a t et h ep r e v a l e n c eo fH I Vi n f e c t i o nf r o mH I Va t t r i b u -
table mortality, the reverse of the WHO procedure, and
relate this to trends in HIV infection.
METHODS
We combined direct estimates of deaths from AIDS
from a nationally representative mortality survey
17
1Centre for Global Health Research,
Li Ka Shing Knowledge Institute, St
Michael’s Hospital, Dalla Lana
School of Public Health, University
of Toronto, Toronto, Canada
M5C1N8
2School of Public Health,
Postgraduate Institute of Medical
Education and Research,
Chandigarh-160012, India
3National AIDS Control
Organization, Ministry of Health
and Family Welfare, Government
of India, Janpath, New Delhi,
110001, India
4National Institute of Health and
Family Welfare, Munirka, New
Delhi, 110067
5Epidemiological Research Centre,
Kilpauk Garden Colony, Chennai,
600 010, Tamil Nadu, India
6Osmania Medical College, Koti
City, Hyderabad, Andhra Pradesh,
India
7Department of Community
Medicine, United Arab Emirates
University, P O Box 17666 Al Ain,
United Arab Emirates
Correspondence to: P Jha
prabhat.jha@utoronto.ca
Cite this as: BMJ 2010;340:c621
doi:10.1136/bmj.c621
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deathsfromdiseasesotherthanAIDS(notablytubercu-
losis) that may have HIV infection as the underlying
cause of death. We applied a maximal observed excess
ofHIVattributablemortalityfromtuberculosisin1990-
2000inselectedurbanhospitals
18toselectednon-AIDS
diseasesinourmortalitysurvey.Wecomparedouresti-
matesofmortalityfromAIDStotheprevalenceofHIV
infection among pregnant women and adults testing at
voluntary counselling and testing sites.
6 Table 1 shows
the population, years, sample size, and variables extra-
cted from the various data sources.
Nationally representative mortality survey
The Registrar General of India is responsible for the
Sample Registration System, in which several thou-
sandsmallareasarechosen,onthebasisofthepreced-
ing census, to be nationally representative of India’s
population.
17 The 1993 sample covered 1.1 million
homes in 6671 areas (4436 rural and 2235 urban
areas, with an average of 165 homes or about 1000
people per area). Since 2001, 800 Sample Registration
System supervisors have visited all homes where a
death had been recorded to collect information that
would help to identify the underlying cause of
death.
171920 The average time elapsed between death
and field interview was 2.1 (range 0.5-3.1) years.
Details of the field methods, quality control checks,
and validation results have been published.
1720-25
WedefinedAndhraPradesh,Karnataka,Maharash-
tra, and Tamil Nadu in south India and Manipur and
Mizoram in northeast India as high HIV states on the
basis of the prevalence of HIV in pregnant women.
1
The total population of the high HIV states in 2005
was 192 million for ages 15-49, or 30% of India’s total
populationforthisagegroup,andthesestatestogether
account for about 75% of HIV infections reported
nationally.
6 Injectingdrug use dominatestransmission
inthenortheaststates
6;althoughthiscomplicatesinter-
pretationofHIVtrendsinpregnantwomen,ithaslittle
impactonestimationofmortalityfromHIV.LowHIV
states are the remainder of India (470 million adults
aged 15-49 years; 70% of India’s total). Owing to
operational problems, Nagaland (1% of total deaths
in India) could not be surveyed and was excluded
from the analyses.
Field “verbal autopsy” with central medical adjudication of
causes of death
Mostoftheestimated10millionannualdeathsinIndia
occur without medical certification at the time of
death.
26 Thus, alternative methods to determine the
underlying cause of death are needed.
17 We used an
enhanced version, “RHIME” (representative, re-
sampled, routine household interview of mortality
with medical evaluation),
1719-21 of a “verbal autopsy”
technique (fig 1). The RHIME method relies on the
assumption that most causes of death have distinct
symptoms and signs that can be recognised, recalled,
and reported by household members or associates of
the deceased to a trained, non-medical field worker.
We trained nearly 900 non-medical field interviewers
(800 Sample Registration System supervisors, 100 re-
sampling staff) to interview living household relatives
ofthedeceasedtorecordthesymptoms,signs,andkey
circumstancesleadingtodeath,includingadescriptive
narrative in the local language of the main events and
treatments. Two independent trained physicians
examined scanned images of the written field reports
to assign the causes of death, using a web based man-
agement system.
20 A random sample of about 5% of
the areas was re-surveyed independently by field staff
who had received more training than the Sample
Registration System supervisors and who reported
directly to us. Using the re-sampled deaths at age 15-
59 as the reference diagnosis, the sensitivity and speci-
ficity were 80% and 99% for the 10 re-sampled deaths
from AIDS and 65% and 98% for the 117 re-sampled
deaths from tuberculosis.
ThespecificcriteriafordeathsfromAIDSusedbythe
physicians came from validation studies in Africa,
162728
a cohort study of HIV infected adults not taking anti-
retroviraltreatmentinMumbai,
29andclinicalstudiesin
India.
30-32 The key symptoms for deaths from AIDS
included prolonged (more than one month) fever, diar-
rhoea, or cough; mouth sores or patches; swelling of
lymph nodes; and recent weight loss. If the two physi-
cians did not agree on the three digit ICD-10 (inter-
national classification of diseases, 10th revision) code
of the underlying cause, their forms were reassigned to
each other(anonymously)forreconciliation.
25Ase ni or
physician adjudicated continuing disagreements. We
used relatively non-stringent criteria to define deaths
Table 1 |Sources of data for study
Population Years Sample size Data Source and reference
Million Death Study 2001-3 125 000 deaths in 1.1 million
homes (nationally
representative)
Causes of death by age, sex,
and district
Registrar General of India
17
Medically certified causes of
death from selected urban
hospitals
1990-2000 About 300 000 annual deaths
in 300 urban hospitals of 21
states
Causesofdeathbyageandsex
in urban areas
Registrar General of India
18
Antenatal clinic attenders 2000-7 1 015 780 women at public
clinics
HIVand syphilis status, by key
demographicgroupsinwomen
aged 15-34
National AIDS Control
Organization
6
Voluntary counselling and
testing centre attenders
2003-7 2 207 854 women and 2 405
248 men at public clinics
HIV status by age, sex, and
district in men and women
aged ≥15
National AIDS Control
Organization
6
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onephysiciancodedthecauseasAIDS,ifadiagnosisof
HIV had been recorded by a physician in the past, or if
anykeywordinthehistoryornarrativeincluded“HIV”
or “AIDS.”
Methods to estimate HIV as cause of non-AIDS deaths
HIV infection is a cause of all deaths from AIDS but
also the underlying cause of many deaths attributed to
other diseases, most notably tuberculosis.
1633 Previous
studies worldwide have shown that HIV infection
increases the risk of death from tuberculosis.
34-37 We
used the following method (one that ensured we did
not underestimate deaths from causes other than
AIDS attributable to HIV, which we measured
directly) to estimate total HIV attributable mortality.
Firstly, we quantified the annual age specific probabil-
ity of death from tuberculosis versus other deaths by
using a medically certified cause of death survey of
about 0.3 million annual deaths from more than 300
urban hospitals from 1990-2000.
18 The proportions of
deaths from tuberculosis to total deaths fell at all ages
among men in the low HIV states and among women
in all states (data not shown), but this proportion did
not fall among men aged 25-44 years in the high HIV
states (fig 2). Next, we assumed that this stagnation in
the proportion of deaths from tuberculosis at ages 25-
44 among men in the high HIV states was due to an
excessofHIVattributablemortalityfromtuberculosis.
Wequantifiedthisexcessbycomparingthetuberculo-
sisspecificproportionaldeathratesobservedin1990-3
(beforeHIVinfectionbecamecommoninthesestates)
with those observed in 1994-2000 (when HIV infec-
tion spread rapidly).
24 The upper 99% confidence
limit of this excess was 33.5% at age 25-34 (and 16.8%
at age 15-59), which we doubled, in keeping with our
approach of ensuring minimal underestimation of
HIV attributable mortality. Thus 67.0% of deaths
from tuberculosis at age 25-34 and 33.6% of those at
age 15-59 in our 2001-3 survey were attributable to
HIV in the high HIV states.
Thirdly, we applied this maximal excess of HIV
attributable mortality from tuberculosis to three other
causesthatmayeitherhaveHIVinfectionasanunder-
lying cause or mimic death from AIDS: fever of
unknown origin, lower respiratory infections, and
lymphoma or leukaemia. Fourthly, HIV may well
raise death rates from various other diseases, in part
through extrapulmonary tuberculosis,
3335 and the
underlying cause of death is misclassified with the
RHIME method.
20-24 To account for other HIV attri-
butable deaths from medical causes or injuries not
likely to be caused by HIV, we applied the upper
99% confidence limit of the HIV prevalence among
adults aged 15-49 in the high HIV states tested for
HIV in 2005/6 to the remaining deaths.
12 Finally, we
applied the observed ratio between HIV attributable
deaths due to AIDS and HIV attributable deaths due
to the non-AIDS causes noted above in the high HIV
states to the absolute numbers of AIDS deaths
observed directly in the low HIV states and among
menandwomenseparately.Thelogicwasthattherela-
tionbetweenHIVattributabledeathsduetoAIDSand
HIV attributable deaths not due to AIDS increases or
decreases on the basis of the prevalence of HIV in the
population, as seen in African countries.
2728
Absolute death rates
The Sample Registration System enumeration of indi-
vidual deaths slightly underestimates the overall mor-
talityofIndianadults,
3839andoursurveymissedabout
12% of the enumerated deaths because of out-migra-
tion or because no relative could be found. Thus,
using methods described earlier,
20 we used WHO esti-
matesofagespecificmortality(irrespectiveofcause)in
India for 2004 and partitioned these deaths across
states in proportion to the average of Sample Registra-
tion System death rates for 2003-4.
1740 To these state
specific total deaths, we applied the age and cause spe-
cific proportions from our study.
Geographic comparisons with HIV prevalence in clinic
populations
We compared mortality from AIDS in the districts of
thefourstatesinsouthIndiawithHIVsentinelsurveil-
lance results. The sentinel surveys tested 1015780
women aged 15-34 between 2000 and 2007 nationally
through sequential, unlinked, and anonymous testing
for HIV among pregnant women attending public
antenatal clinics between August and November of
every year.
6 District level data came from self referred
attenders of voluntary counselling and testing centres
aged 15 yearsand above from2003 to 2007(2207854
Part time enumerators
Field data activities
Cause of death assignment
Continuous recording of births and deaths every month
Re-sample team (n=100)
Random resample of 5% of deaths
Dual recording of births and deaths, plus collection of circumstances,
symptoms, signs of illness, and narrative every 6 months or in special survey
Reconciliation between two physicians for ICD-10 code
If no agreement reached, expert physician adjudicates remaining differences in ICD-10 code
RHIME database (123 000 deaths from 2001-3)
Two trained physicians assign cause of death by using ICD-10
RGI surveyors (n=800)
Informs household of RHIME every month
Select fields and copy of narrative extracted
to compose modified web based reports 
Fig 1 | Million Death Study RHIME activities. RGI=Registrar General of India
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recommended methods for screening in developing
countries, using one highly sensitive enzyme linked
immunosorbent assay (ELISA), with positive results
confirmed by a second ELISA.
41 Details of the labora-
tory and quality methods are published.
42
Statistical methods
We estimated the relation of the age specific HIV pre-
valence (P) to HIV attributable mortality in two ways.
Firstly, we used the formula P=1/(((R/M)+1−R)),
whereRistheratioofmortalityofHIVinfectedversus
HIV uninfected adults and M the proportion of all
deaths attributable to HIV, with the accompanying
99% confidence interval, which is based on M.
16 The
values for R were based on a cohort study of HIV
infected adults in Mumbai and clinical studies in
other parts of India,
29-32 divided by all cause death
rates.
43 Secondly, we calculated mortality estimates
on the basis of the assumption of a Weibull survival
distribution with a median survival of 10 years.
27 We
usedthedirectmethodtostandardiseannualHIVpre-
valences to the 2000-7 age distribution of the national
antenatal clinic study population.
44 Spatial representa-
tion of prevalences in antenatal clinics and voluntary
counselling and testing centres used empirical Bayes
smoothing.
45 Isopleth maps used ordinary kriging of
(geo-located) point estimates.
RESULTS
HIV attributable mortality from AIDS
As of July 2009, 132626 death records were available
for all ages, of which 92.7% (122913) were coded by
two physicians. The exclusions resulted from opera-
tional problems with the records (4.9%; 6498) and
missing age, sex, or other information needed for a
finaldiagnosis(2.4%;3215).Aprobablecause(exclud-
ing ill defined causes and senility) was assigned to 96%
(36517) of the 38068 deaths at ages 15-59 years.
Table 2givesthesummaryresultsforthe468deaths
that were recorded as due to AIDS in our study. More
than three quarters (n=353) of deaths from AIDS
occurred in the high HIV states, about four fifths
(370) occurred in men, and more than two fifths (183)
occurred among illiterate adults. About 86% (404) of
deaths from AIDS occurred among Hindus. The per-
centage of deaths from AIDS among Muslims (4%),
who constitute 12% of the Indian population, was dis-
proportionatelylow,perhapsreflectingmalecircumci-
sion status.
46 About 85% (398) of deaths from AIDS
had an earlier diagnosis of HIV by a physician, and
analysesrestrictedtothissubgroupshowedsimilardis-
tributions by state, sex, education, and religion (data
not shown).
Adults who died from AIDS more often had a his-
toryofweightloss(46%)thandidadultswhodiedfrom
tuberculosis (28%) or from other causes (4%) (table 3).
Diarrhoeawasalso morecommon amongpeoplewho
died from AIDS (25%) than among those who died
from tuberculosis or other diseases; fever was equally
commonamongthosewhodiedfromAIDSandtuber-
culosis.DeathsfrombothAIDSandtuberculosismore
commonly occurred at home than did deaths from
other causes. The prevalence of smoking tobacco was
similar amongmen whodiedfromAIDS and tubercu-
losis, but alcohol use was more common among men
who died from AIDS than in those who died from
tuberculosis. Few women in the study smoked or
drank alcohol.
HIV attributable mortality from diseases other than AIDS
Men, but less so women, showed a distinct age pattern
fordeathsfromAIDS,peakingatage25-34(fig3)with
a similar peak for deaths from tuberculosis at this age.
Table 2 |Characteristics of deaths from AIDS (ICD-10 codes B20-B24) at age 15-59 by sex,
from 1.1 million nationally representative homes in India, 2001-3. Values are numbers
(percentages) unless stated otherwise
Characteristic Men (n=370) Women (n=98) Total (n=468)
Mean age (years) 35.5 35.2 35.5
Residence:
Rural 299 (81) 88 (90) 387 (83)
Urban 71 (19) 10 (10) 81 (17)
Education:
Illiterate or below primary 125 (34) 58 (59) 183 (39)
Primary or higher 245 (66) 40 (41) 285 (61)
Religion:
Hindu 318 (86) 86 (88) 404 (86)
Muslim 16 (4) 3 (3) 19 (4)
Christian 20 (5) 5 (5) 25 (5)
Others or unknown 16 (4) 4 (4) 20 (4)
Results exclude people with unknown status for age, religion, or education.
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Age group
(years) High HIV states
Difference in probability of tuberculosis v other deaths for 2000 v 1990 (P value)
15-24
25-34
35-44
45-54
55-64
≥65
13% (0.61)
9% (0.64)
4% (0.44)
-11% (<0.01)
-9% (0.01)
-12% (0.07)
Low HIV states
-1% (0.60)
-4% (0.04)
-2% (0.08)
-18% (0.03)
-21% (0.03)
-13% (0.20)
Fig 2 | Age specific trends in probability of death from tuberculosis versus other diseases
among urban men aged 15 years or older, 1990-2000. The age specific HIV attributable
percentage of deaths from tuberculosis in men in India in the high HIV states in 1994-2000
was 23.5% (99% CI 13.6% to 33.5%) at age 25-34 and 11.8% (6.8% to 16.8%) at age 15-59
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attributed to cancers, digestive disease, or other dis-
eases (data not shown), as might have been produced
by HIV induced extrapulmonary tuberculosis.
35
Table 4 gives estimates of the number of HIV attribu-
table deaths by cause in India at age 25-34 and of the
totalHIVattributabledeathsatage25-34and15-59for
2004. At age 25-34, 8.1% (99% confidence interval
5.0% to 11.2%) of all deaths were attributable to HIV.
AIDS accounted for 40% and tuberculosis for 26% of
HIV attributable deaths at age 25-34. The geographic
and sex related patterns at age 15-59 were similar to
those seen at age 25-34. HIV attributable deaths
accounted for 3.2% (1.9% to 4.6%) of deaths at age
15-59 or, in absolute numbers, about 100000 (59000
to140000)deaths.Theproportionoftotaldeathsattri-
butabletoHIVwassignificantlylargerinthehighHIV
states(9%ofalldeaths)thaninthelowHIVstates(1%),
and was larger in men (4.3%) than in women (1.6%).
Relation of AIDS mortality to HIV prevalence
Figure 4 shows the geographic distribution of deaths
from AIDS as a percentage of all deaths at age 15-49
in the districts of the southern states of Andhra Pra-
desh, Maharashtra, Karnataka, and Tamil Nadu. The
districts where deaths from AIDS represented more
than 10% of the total deaths at ages 15-49 were chiefly
in the same districts where prevalence of HIV in preg-
nant women aged 15-49 attending public antenatal
clinics was above 2% in 2003. Considerable local var-
iation in deaths from AIDS and HIV infection existed
across districts. Notable “hot spots” in 2003 for HIV
infection and AIDS mortality were in the Mumbai-
northern Karnataka corridor and along the eastern
highway areas of Andhra Pradesh.
Further spatial analyses in the high HIV states
showed broad geographic declines in HIV prevalence
between 2003 and 2007 among pregnant women aged
15-24 (fig 5). Among self referred (and hence more
biased) voluntary counselling and testing centre popu-
lations, HIV prevalence declined between 2003 and
2007 among both women (relative decline 42.5%,
99% confidence interval 41.2% to 44.5%) and men
(55.1%, 53.8% to 56.9%). The number of “hot spots”
faded continuously and similarly in antenatal clinic
and voluntary counselling and testing centre popula-
tions between 2003 and 2007. Seropositivity in volun-
tarycounsellingandtestingcentresattendersincreased
in 2007 near Mumbai (formerly Bombay), but not in
young pregnant women, perhaps owing to expansion
of the antiretroviral treatment programme in 2006.
47
Trends in all cause mortality and HIV prevalence
Any major increase in HIV infection should have
increased all cause mortality in young adults, as has
occurred in Africa,
48 because death rates at young
ages are low and competing causes are few. In the
southern high HIV states in 2003, total death rates at
age 25-34 varied from 2 to 3 per 1000 (compared with
about 6-8/1000 at all ages),
40 and the leading causes of
death in men in this age group were, in decreasing
order, intentional and unintentional injuries, cardio-
vascular disease, tuberculosis, AIDS, digestive dis-
eases, and cancers.
17 Increases in all cause mortality
among men aged 25-34 occurred between 1997 and
2002 (fig 6), but the increases stopped by 2002 and
deathrateshavedeclinedsince.IncreasesinHIVattri-
butabledeaths(particularlyfromAIDSandtuberculo-
sis) probably accounted for the 1997-2002 increases,
although competing mortality from increases in inten-
tional injuries cannot be ruled out.
17 In contrast, all
cause mortality in women aged 25-34 fell by about
20% between 1997 and 2007.
In the high HIV states, the age standardised preva-
lence of HIV among pregnant women aged 15-24 fell
Table 3 |Symptoms, place of death, and smoking/drinking history (men) among people who
died from AIDS, tuberculosis, and other causes, ages 15-59 years. Values are numbers
(percentages)
Characteristic
Deaths from AIDS*
(n=468)
Deaths from tuberculosis
(n=4877)
Other deaths
(n=33 788)
Symptoms
Fever 291 (62) 2868 (59) 6543 (19)
Diarrhoea 117 (25) 94 (2) 1936 (6)
Cough 150 (32) 3936 (81) 3144 (9)
Mouth sores or patches 25 (5) 3 (0.1) 71 (0.2)
Weight loss 216 (46) 1375 (28) 1316 (4)
Place of death
Home 372 (80) 3868 (79) 20 742 (61)
Hospital/health facility 58 (12) 661 (14) 7081 (21)
Smoking/drinking (men only)
Smoked tobacco 224/370 (61) 1930/3195 (60) 9408/20 378 (46)
Drank alcohol 221/370 (60) 1364/3195 (43) 6584/20 378 (32)
*Includes only deaths directly attributable to AIDS (see ICD code list in table 4).
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Fig 3 | Age distribution of deaths from AIDS and tuberculosis
by sex at age 15-59 years in 2001-3 in India
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62.2%, 53.8% to 70.7%) (fig 7). Declines were compar-
able when we restricted analyses to the 25 antenatal
clinic sites open continuously for eight years (relative
decline 47.8%, 27.4% to 68.2%). Declines varied little
by literacy, migrant status, or residency (data on
CGHR website at http://cghr.org/ecological_page.
htm)
89 and were similar after exclusion of Tamil
Nadu (where interventions began earliest among the
high HIV states
4) (data not shown). We also saw
declines among pregnant women aged 25-34 (data
not shown). In the low HIV states, age standardised
HIV prevalence estimates were below 0.5% in all age
groups and did not change significantly between 2000
and 2007 among pregnant women aged 15-24 or 25-
34. Declines in both regions seem not to be due to
changes in the type of women being tested in the
antenatal clinic sites (more data on CGHR
website).
89
National HIV prevalence estimates
Table 5 compares estimates of HIV prevalence at age
15-49 and absolute numbers of adults infected in 2004
onthebasisofourmortalitydatawiththeWeibullesti-
mates of national mortality and with the results of
direct testing of adults in a nationally representative
household survey in 2005/6.
12 All three estimates are
comparable, ranging from 0.25% to 0.28% with over-
lapping confidence intervals.
DISCUSSION
HIV attributable deaths
Our estimates of mortality in India suggest that about
100000 adults (range 59000-140000) aged
15-59 years died from HIV infection in 2004. Our
results differ from WHO’s 2003 estimate of at least
270000 deaths,
14 but they are broadly consistent with
earlierindirectestimatesofmortalityinIndiaandwith
WHO’s revised estimate of 127000 deaths from HIV
Table 4 |Estimates of numbers of deaths in adults directly and indirectly attributable to HIV, subdivided by ages 25-34 and 15-59 years and by disease
group, state, and sex, India, 2004
Number attributable to HIV/total (in thousands)
% of HIV attributable
deaths
By state, both sexes India, by sex
High HIV states* Low HIV states* Men Women Both
Age 25-34, by cause of death† †
AIDS 13.9/13.9 2.4/2.4 12.8/12.8 3.5/3.5 16.3/16.3 40
Tuberculosis 8.9/13.4 1.5/50.6 8.2/36.6 2.2/27.4 10.4/64.0 26
Feverofunknownorigin 6.7/10.1 1.2/26.3 6.2/18.7 1.7/17.7 7.9/36.4 19
Lower respiratory
infections
0.1/0.2 0.02/3.1 0.1/1.9 0.02/1.4 0.1/3.3 0.3
Lymphomas or
leukaemia
3.2/4.8 0.6/17.2 2.9/9.6 0.8/12.4 3.8/22.0 9
Other causes 1.7/96.4 0.3/260.7 1.6/213.6 0.4/143.5 2.0/357.1 5
All HIV attributable causes/total deaths (%, 99% CI)
Age 25-34 34.5/138.8
(24.9, 19.2 to 30.5)
6.0/360.3
(1.7, 0.1 to 5.4)
31.8/293.2
(10.8, 6.8 to 14.9)
8.7/205.9
(4.2, 0.1 to 9.1)
40.5/499.0
(8.1, 5.0 to 11.2)
100
Age 15-59 78.3/868.0
(9.0, 6.5 to 11.5)
21.3/2211.9
(1.0, 0.1 to 2.5)
78.9/1821.9
(4.3, 2.6 to 6.0)
20.7/1258.0
(1.6, 0.1 to 3.8)
99.6/3079.9
(3.2, 1.9 to 4.6)
100
*High HIV states are Andhra Pradesh, Karnataka, Maharashtra, Tamil Nadu, Manipur, and Mizoram; remainder are low HIV states; Nagaland was excluded.
†Cause specific totals are from this study, adjusted to total number of deaths from all causes from WHO for 2004 and to states using relative Sample Registration System death rates for
2004 (results were nearly identical if 2002 or 2003 totals were used; no trend seen in 2001-3 calendar years). ICD-10 categories: AIDS (B20-B24, R75); tuberculosis (A15-19, B90), includes
respiratory tuberculosis and other tuberculosis; fever of unknown origin (R50), lymphomas/leukaemia diseases (C81-96); lower respiratory infection (J10-18, J20-22), includes influenza,
pneumonia, and acute bronchitis; other or unspecified disease (all of A-N and R-Y except above), includes completely ill defined (R99, 2.1% of this subgroup) but excludes maternal deaths
(O) in women.
Andhra Pradesh
Tamil Nadu
Maharashtra
Karnataka
HIV prevalence among ANC
attendees aged 15-49, 2003
Percentage of deaths among adults
aged 15-49 attributed to AIDS, 2001-3 
<1%
1-2%
>2%
<3%
3-10%
>10%
Fig 4 | HIV prevalence among women aged 15-49 years in
2003 and AIDS as a percentage of deaths at age 15-49 among
districts in the four southern states in 2001-3. 115 districts
(using 2001 census boundaries) are included for antenatal
clinic (ANC) sites; 94 districts (using 1991 census boundaries)
are included for mortality
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results.
154950 Notwithstanding uncertainty in our esti-
mation methods, HIV seems to have accounted for
about 1 in 12 deaths at age 25-34 in India in 2004.
The markedly higher proportion of HIV attributable
deathsinthehighHIVstatesthaninthelowHIVstates
wasconsistentwiththefour orfivetimeshigherpreva-
lenceofHIVamongpregnantwomeninthehighHIV
states.
6
Since 1995, short course treatment of tuberculosis
has expanded more in the high HIV states than in the
lowHIVstates.
51Despitethis,HIVinfectionprobably
contributed to a marked stagnation between 1990 and
2000 in the proportion of mortality from tuberculosis
compared with total mortality in men in urban areas
aged 25-44 in the high HIV states, to increases in all
cause mortality at age 25-34 between 1997 and 2002,
and to a corresponding age specific excess in deaths
from tuberculosis among men in our 2001-3 mortality
survey (fig 2).
Expanded antiretroviral treatment cannot explain
ourresults;thecumulativenumberofadultsusinganti-
retroviral was only 57000 as of 2006 (only a modest
increase from earlier years), 180000 as of 2008, and
about 250000 as of 2009.
47 In the future, AIDS treat-
ment may well result in increased survival of people
withHIVinfectionandhenceresultinahigheroverall
prevalenceofHIV.However,aslongascoveragewith
antiretroviral treatment remains low (below a third if
wecomparethemaximalcoverageof250000ontreat-
ment in 2009 with the lowest estimate of 0.75 million
HIVinfectedadultsin2004),trendsinHIVprevalence
will largely reflect (with delay) trends in incidence of
infection.
Implications for national prevalence and surveillance
Systematic data on incidence of HIV or deaths from
AIDS over prolonged periods to accurately measure
prevalence of HIV are not available in India or most
lowincomecountries.
10Ourestimatesofprevalenceof
HIV based on mortality depended on the mortality
ratio between HIV infected and uninfected people,
but our ratio is plausible and consistent with ratios
observed elsewhere.
16 Our mortality based estimate
of HIV prevalence of approximately 0.26% at age 15-
49 is consistent with the 0.28% estimate from nation-
ally representative testing for HIV in 2005/6,
12 as well
as with our observed ratio between prevalence and
mortality. Collectively, all three methods suggest that
India had about 1.4 to 1.6 million HIV infected adults
aged15-49in2004-6,wellbelowtheofficialestimateof
2.3 million (range 1.9-3.0 million) in this age group.
1
Indeed, our estimates of HIV prevalence might well
be construed as upper limits.
2003
2004
2005
2006
2007
21.46%
AP
MH
KN
TN
VCTC men,
all ages
VCTC women,
all ages
ANC women,
age 15-24
20.68%
19.41%
12.79%
9.63%
1.10%
1.06%
1.07%
0.87%
0.79%
14.44%
14.59%
14.20%
11.02%
8.30%
Fig 5 | Spatial distribution of HIV prevalence among antenatal
clinic (ANC) and voluntary counselling and testing centre
(VCTC) attenders in high HIV states, 2003-7. This procedure
interpolates prevalence rates between specific point locations
to generate a continuous surface.
45 District aggregated VCTC
prevalence estimates were geo-located to the district’s
centroid (geometric centre). HIV prevalence estimates were
geo-located to the city/town of each testing site. For VCTC
maps, isolines are drawn at 40%, 30%, 20%, and 7.5% (red to
yellow). VCTC maps for all years use same colour scale. For
ANC maps, isolines are drawn at 5%, 4%, 2%, and 1% (red to
yellow). ANC maps for all years use same colour scale.
Percentages are overall prevalence. AP=Andhra Pradesh,
KN=Karnataka, MH=Maharashtra, TN=Tamil Nadu. District
boundaries are as in fig 4
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Fig 6 | Trends in all cause mortality rates at ages 25-34 in
southern states, 1996-2007. Sample Registration System
death rates are calculated on basis of two year rolling
averages starting with 1996 death rates, weighted by
population size for Andhra Pradesh, Karnataka, Maharashtra,
and Tamil Nadu
Table 5 |Estimated prevalence of HIV at ages 15-49 years in India, by three different methods
Method/year
% prevalence
(99% CI)
Millions of adults
infected (99% CI)
Mortality based prevalence,MillionDeath Study,2004 0.26 (0.13 to 0.39) 1.49 (0.75 to 2.19)
Ratio of prevalence to mortality, based on survival
function, using national mortality totals for 2004
0.25 (0.13 to 0.31) 1.42 (0.71 to 1.76)
HIV testing, NHFS-3, 2005-6 0.28 (0.23 to 0.35) 1.59 (1.31 to 1.99)
NHFS=national family health survey.
See web appendix B for methodological note.
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national HIV prevalence (range 0.36-0.41% at age 15-
49) involved an upward adjustment to the recorded
prevalence in the 2005/6 HIV survey to account for
non-sampled populations,
1011 such as migrant men,
that are presumed to be at higher risk of HIV. How-
ever, this somewhat arbitrary upward adjustment may
have overestimated actual prevalence, especially as
use of condoms with non-regular partners (chiefly
commercial sex) rose sharply between 2001 and 2006
among men at high risk.
5253
The increases in overall mortality among men aged
25-34 levelled off by 2002 and subsequently fell, and
HIV infection in pregnant women fell continuously
between 2000 and 2007. This suggests that no major
increase in HIV infection has occurred over the past
few years (and, moreover, that, unlike in Uganda,
4854
major increases in mortality do not explain the
decreases in HIV prevalence). Indeed, overall HIV
prevalence (and probably HIV attributable deaths)
may have fallen further since 2004.
Our study also raises the possibility of monitoring
HIVinfectionandHIVattributablemortality.Wesug-
gest four methods to yield important data on preva-
lence, incidence (at least proxy incidence of prevalent
infections in younger adults), and mortality. These are
larger and better cohort studies of HIV infected popu-
lations on antiretroviral treatment or not, reporting of
causesofdeathbyusingmethodssimilartothoseofthe
Registrar General of India,
17 periodic validation of
population based HIV testing,
10 and expanded senti-
nel surveillance(including voluntarytestingsites) with
periodic behavioural surveys. In India, and in other
low income countries, this routine surveillance system
offers low cost, long term, and sustainable monitoring
oftheevolutionoftheHIVepidemicandtheeffective-
ness of prevention and treatment services.
Limitations: biases and misclassification
Our sample was nationally representative of all deaths
in India but would tend to miss people who were
homeless or living alone when they died; overall, we
obtainedinformationon88%ofallenumerateddeaths.
Migrant adults would be less likely to be missed in our
surveythaninthe2005/6HIVsurvey,
12astheSample
Registration System continuously enumerates house-
hold membership and death.
1940 Anecdotal evidence
suggests that rural migrants tend to come back to
their village to die. Indeed, we found that a greater
proportion of the people who died from AIDS had
States Clinic
High HIV
Low HIV
All sites %
(99% CI)
Continuous sites %
(99% CI)
All sites %
(99% CI)
Continuous sites %
(99% CI)
1.96
(1.57 to 2.34)
1.90
(1.45 to 2.35)
0.32
(0.19 to 0.46)
0.31
(0.17 to 0.45)
1.63
(1.33 to 1.92)
1.71
(1.29 to 2.13)
0.21
(0.13 to 0.29)
0.26
(0.13 to 0.39)
1.53
(1.27 to 1.79)
1.79
(1.38 to 2.20)
0.33
(0.23 to 0.42)
0.36
(0.21 to 0.51)
1.10
(0.99 to 1.22)
1.62
(1.21 to 2.03)
0.25
(0.19 to 0.31)
0.38
(0.22 to 0.54)
1.06
(0.96 to 1.17)
1.10
(0.77 to 1.43)
0.27
(0.19 to 0.35)
0.32
(0.18 to 0.46)
1.07
(0.96 to 1.17)
1.20
(0.85 to 1.55)
0.28
(0.20 to 0.37)
0.12
(0.03 to 0.27)
0.87
(0.78 to 0.97)
1.04
(0.72 to 1.36)
0.25
(0.20 to 0.30)
0.26
(0.13 to 0.39)
0.74
(0.65 to 0.82)
0.99
(0.68 to 1.30)
0.23
(0.18 to 0.28)
0.20
(0.08 to 0.31)
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Fig 7 | Trends in HIV prevalence among pregnant women aged 15-24 from 2000-7 in high and low HIV states. Low HIV states
exclude northeast states (about 1.2% of India’s population), as injecting drug use dominates transmission in this region and
may not be reflected well in trends of HIV in pregnant women. HIV prevalence estimates are age standardised to aggregate
study population, 2000-7. All trend tests are adjusted for age, literacy, urban/rural residence, migrant status, state, clinic
type, and year. Annual number of antenatal clinic attenders of all ages tested each year (2000-7) in high HIV states were
9599, 12641, 15030, 59404, 63105, 63240, 64283, and 67265; numbers in low HIV states were 12386, 22386, 25764,
44790, 26704, 26248, 68207, and 71356. Numbers of surveillance sites in high HIV states were 36, 48, 54, 220, 234, 234,
235, and 242 (with 25 continuous sites); numbers in low HIV states were 56, 100, 114, 215, 118, 119, 339, and 345 (with 45
continuous sites)
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other causes (data not shown).
We found a reasonably good sensitivity and specifi-
city for both deaths from AIDS and those from tuber-
culosis in the original survey compared with the re-
sampled causes of deaths, and our results were also
comparable to those of earlier validation studies that
compared diagnosis of tuberculosis by using the
RHIMEverbalautopsytechniquewiththatinhospital
records.
24 Moreover, the broad pattern of symptoms
for deaths from AIDS, most importantly marked
weight loss, was consistent with clinical studies of peo-
ple with AIDS.
1629-32 The field workers made no judg-
ment on HIV status, which would tend to discourage
reporting of key symptoms by living respondents.
Finally, about 85% of the people who died from
AIDS had a medical history of HIV infection. Still,
verbal autopsy methods misclassify the underlying
causes of some deaths.
161719-24 Absolute underestima-
tion of HIV attributable deaths would most likely
occur if tuberculosis is misclassified with causes of
death other than AIDS. Our indirect method to calcu-
late HIV attributable deaths from causes other than
AIDS is crude. However, we have consistently erred
on the side of overestimation of these proportions.
55
Conclusion
HIV attributable death and infection in India is sub-
stantial, although lower than previously estimated.
Our mortality results are consistent with the reported
declines in prevalence of HIV infection between 2000
and 2007.
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